Two cancer drugs have been successfully combined, with the Melbourne researchers hoping it will be a breakthrough in the treatment of metastatic breast cancer.
In a world first, breast cancer researchers at The Royal Melbourne Hospital and Peter MacCallum Cancer Centre joined venetoclax, a drug that has shown promise in the treatment of chronic leukaemia, with tamoxifen, a therapy used to treat breast cancer.
"Although the study was aimed at determining safety and finding the right dose, we found that 75 per cent of the women involved in the study experienced an overall improvement or derived clinical benefit," Professor Geoff Lindeman, principal investigator of the study, said in a statement.
© AAP 2018
Image credits: Bill Branson (photographer) [Public domain], via Wikimedia Commons; and MesserWoland [GFDL (http://www.gnu.org/copyleft/fdl.html), CC-BY-SA-3.0 (http://creativecommons.org/licenses/by-sa/3.0/) or CC BY-SA 2.5 (https://creativecommons.org/licenses/by-sa/2.5)], via Wikimedia Commons